Protein-arginine deiminase type-2, PAD-H19, Peptidylarginine deiminase II, Protein-arginine deiminase type II, PADI2, KIAA0994, PDI2
Product description
This gene encodes a member of the peptidyl arginine
deiminase family of enzymes, which catalyze the post-translational
deimination of proteins by converting arginine residues into
citrullines in the presence of calcium ions. The family members
have distinct substrate specificities and tissue-specific
expression patterns. The type II enzyme is the most widely
expressed family member. Known substrates for this enzyme include
myelin basic protein in the central nervous system and vimentin in
skeletal muscle and macrophages. This enzyme is thought to play a
role in the onset and progression of neurodegenerative human
disorders, including Alzheimer disease and multiple sclerosis, and
it has also been implicated in glaucoma pathogenesis. This gene
exists in a cluster with four other paralogous genes. [provided by
RefSeq].1) Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :
Immunogen
This PADI2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 557-586 amino acids from the C-terminal region of human PADI2.
Western blot analysis in MDA-MB231 cell line lysates (35ug/lane).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.